[1] |
National Clinical Research Centre for Infectious Disease/The Third People’s Hospital of Shenzhen, Peking University Shenzhen Hospital, Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Shenzhen Key Laboratory of Inflammatory and Immune Diseases.
Expert consensus on diagnosis and treatment of latent tuberculosis infection in patients with rheumatic diseases
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 869-879.
|
[2] |
Ultrasound Professional Committee of Tuberculosis Branch of Chinese Medical Association, Interventional Ultrasound Professional Committee of Interventional Physician Branch of Chinese Medical Doctor Association Danwei.
Expert consensus on ultrasound diagnosis, classification and interventional therapy of tuberculous pleurisy (2022 Edition)
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 880-897.
|
[3] |
Bao Rong, Gao Jianfeng, Rao Yan.
Pathological types and characteristics of experimental pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 898-905.
|
[4] |
Wang Yuxiang, Chen Qiuqi, Yu Xinxin, Zhan Senlin, Zhang Peize, Deng Guofang.
3HP regimen in the treatment of rheumatic diseases complicated with Mycobacterium tuberculosis latent infection:a prospective study
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 906-910.
|
[5] |
Xie Jingyi, Zou Ruifeng, Chen Yulan, Chen Yong, Liu Dongzhou, Hong Xiaoping.
Analysis of clinical features and peripheral lymphocyte subsets of systemic lupus erythematosus patients complicated with tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 911-916.
|
[6] |
Cheng Xiao, Chen Zhe, Jiao Xuefeng, Yang Nan, Diao Sha, Ni Xiaofeng, Liu Zheng, He Siyi, Zeng Linan, Wan Chaomin, Kang Deying, Wu Bin, Ying Binwu, Zhang Hui, Zhao Rongsheng, Zhang Lingli.
Efficacy and safety of recombinant Mycobacterium tuberculosis fusion proteins (EC) for the diagnosis of Mycobacterium tuberculosis infection: A system review
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 917-926.
|
[7] |
Wang Ni, Huang Fei, Zhu Limei, Zeng Yi, Zhang Ruimei, Geng Hong, Liu Xuefa, Zheng Jiangang, Zong Peilan, Zeng Zhong, Li Jinlan, Cai Cui, Guo Xiaohong, Zhong Yin, Liu Li, Xie Yan, Du Fangfang, Zhou Lin, Cheng Shiming.
Implementation study on promoting the use of anti-tuberculosis fixed-dose combination in provincial and prefecture tuberculosis designated hospitals
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 927-933.
|
[8] |
Wei Ganhui, Zhang Jiacheng, Qiu Xiaowei.
Application value of volume CT value inquantifying the activity of pulmonary tuberculosis lesions above 5 mm
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 934-939.
|
[9] |
Wang Chaohong, Sun Qing, Liao Xinlei, Yan Jun, Wang Chenqian, Jiang Guanglu, Wang Fen, Xue Yi, Huang Hairong, Wang Guirong.
Analysis of drug resistance situation of Mycobacterium tuberculosis strains from 231 spinal tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 940-946.
|
[10] |
Nie Tingyue, Chen Wei, Zhang Jieying, Cao Hong, Qian Bing, Gu Yingqiang, Liu Xuxiang.
Analysis of spatial distribution characteristics of pulmonary tuberculosis cases in Hefei City, 2009—2020
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 947-953.
|
[11] |
Wu Wenqi, Zhong Jianqiu, He Juan, Deng Guofang, Wang Qingwen.
The research progress of the reactivation of latent tuberculosis infection in patients with rheumatic diseases
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 954-959.
|
[12] |
Chen Qiuqi, Han Tingting, Wang Qingwen, Deng Guofang.
Recent advances in treatment of latent tuberculosis infection complicated with rheumatic diseases
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 960-965.
|
[13] |
Han Xu, Guan Shangqi, Shi Yinpeng, Mei Yifang.
The risk of tuberculosis infection with non-tumor necrosis factor-targeted drugs in the treatment of rheumatoid arthritis
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 966-972.
|
[14] |
Yao Rong, Lu Yu.
Research progress on the drug resistance and mechanism of the anti-tuberculosis drug bedaquiline
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 973-977.
|
[15] |
Xie Fanghui, Liang Li, Zhao Xia, Yao Rong, Lei Limei, Guo Hui, Meng Meng, Wan Bin.
Research progress of sputum specimen collection in patients with pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(9): 978-982.
|